These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 4149315

  • 1. Mechanisms of immunosuppression by antilymphocyte antibody.
    Taub RN.
    Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
    [No Abstract] [Full Text] [Related]

  • 2. Biological effects of heterologous antilymphocyte serum.
    Taub TN.
    Prog Allergy; 1970; 14():208-58. PubMed ID: 4404047
    [No Abstract] [Full Text] [Related]

  • 3. Developmental aspects of delayed hypersensitivity.
    Berkel AI.
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:147-51. PubMed ID: 4277433
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP.
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract] [Full Text] [Related]

  • 6. Tolerance and suppressor T cells.
    Brent L.
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract] [Full Text] [Related]

  • 7. Selective loss of suppressor cell function in New Zealand mice induced by NTA.
    Klassen LW, Krakauer RS, Steinberg AD.
    J Immunol; 1977 Sep; 119(3):830. PubMed ID: 19534
    [No Abstract] [Full Text] [Related]

  • 8. The mechanism of action of heterologous anti-lymphocyte sera. I. "In vitro" activity and their effects on different aspects of immunity in rats.
    Kahan A, Jouanneau M, Brouilhet H, Delbarre F, Charles A.
    Biomedicine; 1973 Jan; 18(1):69-77. PubMed ID: 4576461
    [No Abstract] [Full Text] [Related]

  • 9. Immunological facilitation, a broadening of the concept of the enhancement phenomenon.
    Voisin GA.
    Prog Allergy; 1971 Jan; 15():328-485. PubMed ID: 4151281
    [No Abstract] [Full Text] [Related]

  • 10. [Immunological concepts relating to organ transplantation].
    Dei Poli G, Massa G, Rosso PA, Dei Poli N.
    Minerva Chir; 1980 Jun 15; 35(11):829-78. PubMed ID: 6450338
    [No Abstract] [Full Text] [Related]

  • 11. Uptake of antilymphocyte globulin by human peripheral lymphocytes.
    Brain P, Marston RH.
    Clin Exp Immunol; 1973 Mar 15; 13(3):423-6. PubMed ID: 4633851
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histocompatibility in humans.
    Fotino M.
    Ann Clin Lab Sci (1971); 1971 Mar 15; 1(2):125-30. PubMed ID: 4405210
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Antilymphocyte serum. I].
    Bach JF.
    Rev Eur Etud Clin Biol; 1970 Jan 15; 15(1):28-55. PubMed ID: 4393724
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP, Liegeois A, Wood ML, Clark AW.
    Adv Nephrol Necker Hosp; 1975 Jan 15; 5():135-72. PubMed ID: 242206
    [No Abstract] [Full Text] [Related]

  • 19. Cancer in immunosuppressed experimental animals and human patients.
    Allison AC.
    Johns Hopkins Med J Suppl; 1974 Jan 15; 3():341-51. PubMed ID: 4370940
    [No Abstract] [Full Text] [Related]

  • 20. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT, Wagner H.
    J Immunol; 1972 Dec 15; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.